Navigation Links
Group Seeks Refinement of Knee Arthritis Treatment Guidelines
Date:12/10/2007

Changes should stress education, patient activity management interventions, review finds

MONDAY, Dec. 10 (HealthDay News) -- Six sets of guidelines for the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of knee osteoarthritis (OA) published or updated between 2001 and 2006 contain differences and a lack of educational information, according to a review published in the online journal Arthritis Research & Therapy.

The guidelines were meant to address concerns over cardiovascular risks associated with NSAIDs.

The review was conducted by an international team of 13 clinical researchers, including rheumatologists, physiotherapists, occupational health experts and general practitioners. They used the Appraisal of Guidelines Research and Evaluation (AGREE) criteria to evaluate the guidelines.

The guidelines recommend acetaminophen for initial pain treatment, combined with exercise and education. If this fails to control pain, NSAIDs are the next option but should be used cautiously due to gastrointestinal (GI) risks. Surgery may be required for persistent pain and disability.

The reviewers said most of the guidelines discuss education and patient activity management interventions superficially, and they recommend that future guidelines should contain more detail about these aspects.

The reviewers also found the guidelines effectively addressed only a few of AGREE criteria.

"To improve applicability and increase uptake by end users, stakeholder opinions and barriers in use need to be taken into account during guideline development," the reviewers wrote.

They noted that guideline development and dissemination of new knowledge are slow processes and recommended development of innovative methods of providing new knowledge to health professionals.

More information

The American Academy of Family Physicians has more about

Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
5. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
6. UTC Power Acquires Dome-Tech Group
7. Sutter Health Medical Groups Among the Best for Health Care Quality
8. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
9. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
10. AMERIGROUP to Acquire Memphis Health Plan
11. Securians Minnesota Life Continues to Climb Group Life Rankings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...er Medical Center (URMC) has received a U.S. paten... accurately screen for organisms such as bacteria ...s, LLC, a Rochester-based life sciences company, i...chnology. , The company,s technology platform ...ng genetic sequences from biological samples, a pr...
(Date:1/8/2009)...n. 8 The flu season will likely hi...ts from the national Centers,for Disease Control ...rents,and teachers to take action to help reduce ...t on the battle against the spread of germs, parti...rently attending or working at a school(1). , ...
(Date:1/8/2009)...PRNewswire/ -- CrossTech Forums today announced th... national invitational summit featuring a content ...company, will now take place at the Arizona Grand ...09. Originally scheduled for January 2009 in Jacks...hoenix resort in order to accommodate expanded con...
(Date:1/8/2009)...ing and can lead to severe depression yet pain is...egarded as ,normal, in later life. Now a new study...people,s experiences of pain and how best Governme...he issue. , The report, Pain in older people: r...perspective , aims to highlight the issue of pain ...
Breaking Medicine News(10 mins):Health News:URMC, Lighthouse Biosciences awarded US patent for diagnostic technology 2Health News:Clorox Partners With PTA to Help Parents and Teachers Prepare for Height of Flu Season 2Health News:Clorox Partners With PTA to Help Parents and Teachers Prepare for Height of Flu Season 3Health News:Clorox Partners With PTA to Help Parents and Teachers Prepare for Height of Flu Season 4Health News:CrossTech Forums Announces Health IT Insight 2009 Moving to Arizona Grand Resort in Phoenix; Executive Summit to Take Place April 29-May 1 2Health News:CrossTech Forums Announces Health IT Insight 2009 Moving to Arizona Grand Resort in Phoenix; Executive Summit to Take Place April 29-May 1 3Health News:A life with pain -- new study examines the experiences of older people 2Health News:A life with pain -- new study examines the experiences of older people 3Health News:A life with pain -- new study examines the experiences of older people 4
...ceived could be preventing a fatal traffic acciden...o studied the impact of traffic convictions on the...rash. Results show drivers run a significantly low...onth after a traffic conviction when compared to o...
...by animals poses little problem for doctors, but w...at’s the question researchers set out to answer in...ogy -- Head and Neck Surgery. Their review of 10 y... Texas, identified several key areas they believe ...
...rms that some people are much more sensitive to pa...ing patients' descriptions of their pain. "One of...een having confidence in the accuracy of patients'...ll, an assistant professor of neurobiology and ana...
... to prevent or delay the onset of prostate cancer,...th of high-grade cancers. More than 18,000 men wer.../day or placebo. At baseline, digital rectal exami...s, and prostate-specific antigen (PSA) levels// we...
Other Medicine News:
(Date:1/7/2009)...wswire/ -- ImQuest Life Sciences announced today t...the Food and Drug Administration to initiate human...V inhibitor IQP-0410. ImQuest anticipates initiati...009. IQP-0410 is a novel small molecule inhibitor ...erse transcriptase inhibitor (NNRTI). The compound...
(Date:1/7/2009)... 7 Circassia Ltd, a specialty,bio...ical care, today,announced that following success...leroMune(R) anti-allergy technology, the company h...r phase II clinical trial in cat allergy. The,stu... patients with confirmed,cat allergies, and all t...
(Date:1/6/2009)...swire/ -- In recent controlled studies conducted b...ientists found that the patented ingredient in Gly...oven ingredient to increase levels of nitric oxide...e/nitrate (NOx) in human subjects. , , Nitric o... in blood flow to the skeletal muscles. This is s...
(Date:1/6/2009)...Newswire/ -- Cequent Pharmaceuticals, a pioneer in...-based treatments to prevent and treat human disea...ted a successful toxicology study of its candidate...ic targeting the primary oncogene (beta-catenin, C...P is an inherited gastrointestinal disease that ca...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3SYMLIN Pen Injector Devices Now Available 9144 1SYMLIN Pen Injector Devices Now Available 9144 2SYMLIN Pen Injector Devices Now Available 9144 3SYMLIN Pen Injector Devices Now Available 9144 4William Garland Joins AngioGenexs New Board of Directors 2482 1William Garland Joins AngioGenexs New Board of Directors 2482 2William Garland Joins AngioGenexs New Board of Directors 2482 3DRI Capital Launches Structured Finance Fund 2479 1DRI Capital Launches Structured Finance Fund 2479 2Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG GCSF 1151 1Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG GCSF 1151 2Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG GCSF 1151 3Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG GCSF 1151 4
... & NEW DELHI, India--(BUSINESS WIRE)--Jun 21, ...ed non-profit,pharmaceutical company, today announ...roved drug product, Paromomycin IM,Injection (Paro...e,New England Journal of Medicine (NEJM). This cli... safe, effective, and well suited,to curing viscer...
...t Comprehensive Survey Provides New Benchmark on M... 2007 /PRNewswire-USNewswire/ -- The,following was...st nationwide study of the prevalence of Methicill... a virulent multi-drug resistant organism, ...alence study findings significantly exceed previou...
Other Medicine Technology:Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2
...ons. Most gels can be dried by positioning them on...g them with wet semi-permeable cellophane and clam.... Tut's Tombs also produce great fluorographs. Ord...the gel to be dried. Note our cellophane is less t...
Each GelAir™ system drying frame includes two main components, a plastic drying outer frame and a metal square inner frame, as well as 8 clamps per frame. Supplied as a set of two frames.
...nd oil-free vacuum pump into one housing, allowing... The extremely versatile gel drying system can dry...and multiple mini-gels as well as drying large seq... Integrated Gel Drying System eliminates setup and...
Inquire
Medicine Products: